Saturday, November 17, 2012
Print Current Day:
|
|
SESSION 41 SCHEDULE | |
Saturday
SESSION 41:
NEW DEVELOPMENTS IN AAAS AND THEIR TREATMENT (5-MINUTE TALKS)
Moderators:K. Wayne Johnston, MD, FRCS / Dhiraj M. Shah, MD
|
|
x | |
6:40 AM - 6:45 AM | Impact Of A Redeployable AAA Stent-Graft (Gore Excluder C-3) To Improve Proximal Seal In Difficult Anatomy: Does It Make A Difference |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
6:46 AM - 6:51 AM | Is A Thick Layer Of Neck Thrombus A Contraindication For EVAR |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
6:52 AM - 6:57 AM | Final Result Of The PEVAR Trial: A RCT Comparing Percutaneous With Open Access For EVAR |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
6:58 AM - 7:03 AM | Open And Endovascular Repair Of Para-Anastomotic Aneurysms |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
7:04 AM - 7:09 AM | Transecting The Left Renal Vein For Aortic Surgery: Why, How, When, Where And Why Not |
Presenter(s):Afshin Assadian, MD | |
7:10 AM - 7:15 AM | DEBATE: Laparoscopic Vascular Surgery Should Be Growing And Vascular Surgeons Should Learn It And Do It |
Presenter(s):Joseph S. Giglia, MD | |
7:16 AM - 7:21 AM | DEBATE: Why Laparoscopic And Robotic Aortic Surgery Are Losing Their Appeal And Will Not Become Widespread |
Presenter(s):Willem Wisselink, MD | |
7:22 AM - 7:27 AM | The Rise And Fall Of AAAs: The Decreasing Incidence Of AAAs: What Is The Cause |
Presenter(s):Frank A. Lederle, MD | |
7:28 AM - 7:33 AM | Is EVAR Indicated And Justified For Inflammatory AAAs: When Is It Not |
Presenter(s):Samuel R. Money, MD, MBA | |
7:34 AM - 7:39 AM | Is There A Role For AUI Endografts For EVAR In 2012: Should One Be In Your Endovascular Tool Box For Emergency Use |
Presenter(s):Thomas L. Forbes, MD | |
View Abstract | |
7:40 AM - 7:45 AM | Feasibility Of EVAR For Infected AAAs: When Does It Work And When Doesn’t It |
Presenter(s):Chung-Dann Kan, PhD | |
7:46 AM - 7:51 AM | How To Manage Infected Aortic Endografts |
Presenter(s):Edward Y. Woo, MD / Ronald M. Fairman, MD | |
View Abstract | |
7:52 AM - 7:57 AM | Long-Term Quality Of Life Data After EVAR And Open Repair: From The DREAM Trial: Open Repair Wins And Why |
Presenter(s):Jan D. Blankensteijn, MD | |
7:58 AM - 8:03 AM | The Vital Focus On EVAR vs. Open Repair At 15 Years: Is The Game Changing |
Presenter(s):Roger M. Greenhalgh, MD | |
8:04 AM - 8:12 AM | Panel Discussion |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Saturday
SESSION 42:
NEW DEVELOPMENTS IN TREATMENT OF THE AORTA AND ITS BRANCHES (5-MINUTE TALKS)
Moderators:Ross Milner, MD / Jean-Pierre Becquemin, MD, FRCS
|
|
x | |
8:13 AM - 8:18 AM | How Does Transcatheter Intra-arterial Denervation Work: Who Should Be Treated And Who Should Not: Why Is The Artery Not Injured And Are There Dangers From The Treatment |
Presenter(s):Yvonne Bausback, MD / Dierk Scheinert, MD | |
8:19 AM - 8:24 AM | What Are The Secondary Benefits – Other Than Reducing Blood Pressure – To Renal Denervation: When Will This Treatment Be Available In The US And How Long Will All Benefits Last |
Presenter(s):Michael R. Jaff, DO / Ido Weinberg, MD, MSc | |
8:25 AM - 8:30 AM | Status Of Renal PTA And Stenting After ASTRAL And CORAL: What’s New In The Field |
Presenter(s):Thomas A. Sos, MD | |
8:31 AM - 8:36 AM | Frontiers In Renal Artery Stenting: What Does The Future Hold: Better Stents, Better Balloons, Etc. |
Presenter(s):Max Amor, MD | |
8:37 AM - 8:42 AM | Long-Term Outcomes Of PTA And/Or Stenting For Renal Fibromuscular Hyperplasia: What Is The Best Treatment |
Presenter(s):Albeir Y. Mousa, MD / Ali F. AbuRahma, MD | |
8:43 AM - 8:48 AM | Best Method To Assess SMA Stents: How Does Duplex Correlate With Pressure Measurements, CTA And Clinical Outcomes |
Presenter(s):Timothy A. Resch, MD, PhD | |
8:49 AM - 8:54 AM | Early And Late Outcomes Of PTA And Stenting Of Celiac And SMA Occlusive Disease: Advantages, Limitations And Results Up To 10 Years |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
8:55 AM - 9:00 AM | Can The Results Of Mesenteric Revascularization Improve With Covered Stents And Distal Protection Devices |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
9:01 AM - 9:06 AM | How To Treat Isolated SMA Dissections: When Medical vs. Interventional vs. Surgical Therapy |
Presenter(s):Young Wook Kim, MD | |
View Abstract | |
9:07 AM - 9:13 AM | Panel Discussion |
Moderator(s): Enrico Ascher, MD / James C. Stanley, MD | |
9:14 AM - 9:19 AM | DEBATE: Treatment Of Mid-Aortic Syndrome In Young Adults: Interventional Treatment Is Indicated In Some |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
9:20 AM - 9:25 AM | DEBATE: Interventional Therapy Is Never Indicated For Mid-Aortic Syndrome At Any Age: Open Surgery Is Best |
Presenter(s):Wilhelm Sandmann, MD | |
9:26 AM - 9:31 AM | When Are Reentry Devices And Covered Stents Needed For Iliac Occlusive Lesions |
Presenter(s):Jörn O. Balzer, MD, PhD | |
9:32 AM - 9:37 AM | DEBATE: Open Surgery Is Still Needed For Some Aortoiliac Occlusive Lesions: Which Ones |
Presenter(s):Michel S. Makaroun, MD | |
9:38 AM - 9:43 AM | DEBATE: Endovascular Treatment Is Best For All Aortoiliac Occlusive Lesions |
Presenter(s):Martin Malina, MD, PhD | |
9:44 AM - 9:49 AM | Endovascular Treatment Of Juxtarenal Aortic Occlusions Should Always Be Possible Using Chimneys And Other Adjuncts |
Presenter(s):Sonia Ronchey, MD / Nicola Mangialardi, MD | |
9:50 AM - 9:55 AM | Use Of Advanta V12 Covered Stents For Endovascular Reconstruction Of The Aortoiliac Bifurcation To Treat Complex Occlusive Lesions |
Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
View Abstract | |
9:56 AM - 10:20 AM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Saturday
SESSION 43:
FUTURE ISSUES REGARDING HEALTH CARE; CONFLICT OF INTEREST; GOVERNMENT; INDUSTRY RELATIONS; BUSINESS OF MEDICINE; PRACTICE COSTS; AND REIMBURSEMENTS (5-MINUTE TALKS)
|
|
x | |
10:20 AM - 10:25 AM | How To Succeed With A Physician Founded Medical Device Company: The Embrella Device As An Example |
Presenter(s):Jeffrey P. Carpenter, MD | |
10:26 AM - 10:31 AM | Physician Focused Tort Reform By Limiting Expert MD Testimony Fees And Taking Other Accountability Measures: We Physicians Can Stop Medical Malpractice Abuses No Matter What The Damned Lawyers Do |
Presenter(s):O. William Brown, MD, JD | |
View Abstract | |
10:32 AM - 10:37 AM | What Will Health Care Reform Mean To Practicing Vascular Surgeons, Hospitals And Surgical Services |
Presenter(s):Robert M. Zwolak, MD, PhD | |
10:38 AM - 10:43 AM | What’s Happening With Vascular Reimbursement |
Presenter(s):Sean P. Roddy, MD | |
10:44 AM - 10:49 AM | What Is A Vascular Surgeon Worth To A Health Care System: A Look At The Finances Surrounding Vascular Care |
Presenter(s):Michael C. Stoner, MD | |
View Abstract | |
10:50 AM - 10:55 AM | Disclosure And Conflict Of Interest: Have We Gone Too Far Or Not Far Enough |
Presenter(s):Timothy M. Sullivan, MD | |
10:56 AM - 11:01 AM | Current Status Of The Physician-Industry Relationship: Update On What The Government, Our Medical Schools And Our Hospitals Are Doing To Separate Doctors From Industry |
Presenter(s):Barry T. Katzen, MD | |
11:02 AM - 11:07 AM | Physician-Industry Relationships And Conflict Of Interest: No Conflict – No Interest – No Success: How To Deal With The Pitfalls And Problems – Legally And Ethically |
Presenter(s):Scott L. Stevens, MD | |
11:08 AM - 11:13 AM | What Is Happening With The Physician-Industry Relationship In Community Practice |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
11:14 AM - 11:19 AM | Cost Analysis Of Carotid Interventions In Asymptomatic Patients |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
11:20 AM - 11:25 AM | Do Outcomes Of CEA Differ Among Different Specialties – Vascular Surgeons, General Surgeons And Neurosurgeons: Who Does The Best |
Presenter(s):Carlos H. Timaran, MD / Ali F. AbuRahma, MD | |
11:26 AM - 11:31 AM | What Has And Will The FDA Do To Medical Innovation In The US: An Innovator’s Perspective: Will Things Improve |
Presenter(s):Edward B. Diethrich, MD | |
11:32 AM - 11:37 AM | Panel Discussion |
11:38 PM - 11:43 PM | Poster Award Presentation |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Saturday
SESSION 44:
TRIBUTE TO OUR MILITARY (5-MINUTE TALKS)
|
|
x | |
11:43 AM - 11:48 AM | From The Front Lines To The Ivory Tower And Back: How Advances At Walter Reed National Military Medical Center Are Used At The Front |
Presenter(s):Robert Craig, DO | |
11:49 AM - 11:54 AM | A Brief History Of The Tourniquet In Battle |
Presenter(s):Norman M. Rich, MD, FACS, DMCC | |
View Abstract | |
11:55 AM - 12:00 PM | Vascular Surgery Lessons Learned After A Decade Of War In Iraq And Afghanistan |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Saturday
SESSION 45:
LUNCHEON SESSION: NEW OR IMPROVED ENDOVASCULAR DEVICES (5-MINUTE TALKS)
Moderators:Eric L.G. Verhoeven, MD, PhD / Juan C. Parodi, MD
|
|
x | |
12:01 PM - 12:06 PM | Off-The-Shelf Fenestrated VENTANA Device For Renal Revascularization With Juxta And Pararenal AAAs: Clinical Update And Will In Situ Fenestration Be Possible With Newer Multilayer Stretchable PTFE Endograft Coverings |
Presenter(s):Daniel G. Clair, MD | |
12:07 PM - 12:12 PM | Recent Improvements In The Cook Zenith AAA Endograft: How Do They Make A Difference |
Presenter(s):Tara M. Mastracci, MD | |
12:13 PM - 12:18 PM | Update On Advantages And Limitations Of The Lombard AORFIX Graft: When Will It Be Approved In The US |
Presenter(s):Brian R. Hopkinson, ChM, FRCS / Mark F. Fillinger, MD | |
View Abstract | |
12:19 PM - 12:24 PM | Worldwide Experience With The Aptus HELIFX Endostaples: Can They Fix Endoleaks And Prevent Aortic Neck Enlargement And Migration |
Presenter(s):David H. Deaton, MD | |
12:25 PM - 12:30 PM | Update On The NELLIX Device For EVAR: Advantages And Limitations |
Presenter(s):Jeffrey P. Carpenter, MD | |
12:31 PM - 12:36 PM | Advantages And Limitations Of The INCRAFT From Cordis: 1-Year Clinical Data From The INNOVATION Trial |
Presenter(s):Gioacchino Coppi, MD / Dierk Scheinert, MD | |
12:37 PM - 12:42 PM | Description And Clinical Experience With The Anaconda Fenestrated Endograft For Juxta And Pararenal AAAs |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
12:43 PM - 12:48 PM | Worldwide Mid-Term Results (2-Year) Of The Endurant Endograft For AAAs: Does It Expand The Proportion Of Patients Who Can Undergo EVAR Safely And Effectively |
Presenter(s):Dittmar Boeckler, MD / Michel S. Makaroun, MD | |
12:49 PM - 12:54 PM | Current Status Of The Bolton TREOVANCE AAA Endograft: Advantages And Limitations |
Presenter(s):Edward Y. Woo, MD / Ronald M. Fairman, MD | |
12:55 PM - 1:00 PM | Panel Discussion |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Saturday
SESSION 46:
ISSUES RELATED TO TRAINING, CERTIFICATION, SIMULATION, SPECIALTIES, GUIDELINES AND RANDOMIZED CONTROLLED TRIALS (5-MINUTE TALKS)
Moderators:Mario Lachat, MD / Karl A. Illig, MD
|
|
x | |
1:00 PM - 1:05 PM | What’s New With Maintenance Of Certification (MOC) Requirements For Vascular Surgeons |
Presenter(s):Anton N. Sidawy, MD, MPH | |
1:06 PM - 1:11 PM | Recent Developments In The Evolution Of Vascular Training And Training Programs: Current Status Of The 0:5 Programs And Number Of Vascular Surgery Applicants And Spots |
Presenter(s):Karl A. Illig, MD | |
1:12 PM - 1:17 PM | How To Redesign Workflow To Improve Patient Care And Resident Training |
Presenter(s):Richard J. Powell, MD | |
1:18 PM - 1:23 PM | Advantages Of Case Specific Simulator Rehearsal With Endovascular Procedures |
Presenter(s):Isabelle Van Herzeele, MD, PhD | |
1:24 PM - 1:29 PM | What’s New And Better With The Pontresina Vascular Surgery Simulator Course For Trainees |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
1:30 PM - 1:35 PM | Guidelines Are Outdated By The Time They Are Published: Some Examples |
Presenter(s):Janet T. Powell, MD, PhD | |
1:36 PM - 1:41 PM | Randomized Controlled Trials Can Be Misleading Even When Reported In Leading Journals: Guidelines Based On These Trials Can Also Be Misleading |
Presenter(s):Frank J. Veith, MD | |
1:42 PM - 1:47 PM | Advantages And Limitatons Of The OVATION Endograft (TriVascular) For AAA Repair: Based On The 1-Year Global Experience |
Presenter(s):Manish Mehta, MD, MPH | |
1:48 PM - 1:53 PM | Cost Effectiveness Of Different Treatment Strategies For CLI With Gangrene Or Necrosis |
Presenter(s):Michael Belkin, MD | |
View Abstract | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 46 | |
SESSION 47 SCHEDULE | |
Saturday
SESSION 47:
MORE ABOUT HEALTH CARE REFORM, FDA, ETHICS, COSTS, STANDARDS AND GUIDELINES (5-MINUTE TALKS)
Moderators:Kim J. Hodgson, MD / Thomas F. O'Donnell, Jr., MD
|
|
x | |
2:00 PM - 2:05 PM | Impact Of Obamacare On Medicine In The US |
Presenter(s):Clifford J. Buckley, MD / Shirley Buckley, RN | |
2:06 PM - 2:11 PM | Why The Canadian Health Care System Works Better Than Obamacare Will |
Presenter(s):Dheeraj Rajan, MD, FRCPC | |
View Abstract | |
2:12 PM - 2:17 PM | How Should Aviation Training Serve As A Model For Educating Vascular Surgeons |
Presenter(s):John F. Eidt, MD | |
2:18 PM - 2:23 PM | What Has And Will The FDA Do To Medical Innovation In The US: An FDA Consultant’s Perspective: Will Things Improve |
Presenter(s):Thomas J. Fogarty, MD | |
2:24 PM - 2:29 PM | What Is The FDA Doing To Help The US Device Industry Be More Competitive: Is It Working |
Presenter(s):Dorothy B. Abel, BSBME / Kenneth J. Cavanaugh, Jr., PhD | |
2:30 PM - 2:35 PM | How To Get A Physician-Sponsored IDE: Tips And Tricks |
Presenter(s):Benjamin W. Starnes, MD | |
2:36 PM - 2:41 PM | Advantages Of The ESVS (European Society For Vascular Surgery) Guidelines For Vascular Surgery: Some Examples As To Why They Are Better Than US Guidelines |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
2:42 PM - 2:47 PM | Current State Of The SVS Vascular Quality Initiative: Is It Growing And Is It Working |
Presenter(s):Jack L. Cronenwett, MD | |
2:48 PM - 2:53 PM | Vascular Quality Initiatives: A Dark Cloud Behind A Silver Lining: What Are Some Of The Problems And How Can They Be Resolved |
Presenter(s):Scott L. Stevens, MD | |
2:54 PM - 3:10 PM | Panel Discussion And Break Visit Pavilions and Exhibits (2nd and 3rd Floors). EXHIBITS CLOSE AT 3:15 P.M. |
END OF SESSION 47 | |
SESSION 48 SCHEDULE | |
Saturday
SESSION 48:
VASCULAR DISEASE NATURAL HISTORY; MEDICAL TREATMENT; PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators:Vivian Gahtan, MD / Peter F. Lawrence, MD
|
|
x | |
3:10 PM - 3:15 PM | New Developments In Anticoagulant Drugs For Vascular Patients |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
3:16 PM - 3:21 PM | Decision Making Tool For Determining Which CLI Treatment Is Best: Open vs. Endovascular |
Presenter(s):Darren B. Schneider, MD | |
3:22 PM - 3:27 PM | Ongoing Developments In Drug Treatment Of Vascular Disease: Do HDL Raising Drugs Show Promise For Preventing Strokes And MIs |
Presenter(s):Michael R. Jaff, DO / Ron Waksman, MD / Ido Weinberg, MD, MSc | |
3:28 PM - 3:33 PM | Role Of Optimal Medical Treatment In Stroke Prevention: Does It Really Work |
Presenter(s):Michael R. Jaff, DO / Ido Weinberg, MD, MSc | |
3:34 PM - 3:39 PM | DEBATE: The Truth About Statin Toxicity: Has It Been Overplayed By The FDA And By The Media |
Presenter(s):Bruce A. Perler, MD, MBA | |
3:40 PM - 3:45 PM | DEBATE: Statins May Be Harmful And Should Be Used Less |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
3:46 PM - 3:51 PM | How Should We Interpret The JUPITER Trial Showing The Value Of Statins: Has JUPITER Gotten A Bum Rap? |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
3:52 PM - 3:57 PM | Do L-Arginine Supplements Help Vascular Patients: When And How Should They Be Given |
Presenter(s):Vikram S. Kashyap, MD | |
View Abstract | |
3:58 PM - 4:03 PM | Carotid Glomectomy Is A Good Treatment For Syncopal Vasophlegia: How To Do It |
Presenter(s):Erik E. Debing, MD, PhD | |
View Abstract | |
4:04 PM - 4:09 PM | Interactive Telephone Program To Allow Daily Monitoring Of Vascular Patients |
Presenter(s):John (Jeb) W. Hallett, MD | |
4:10 PM - 4:15 PM | Comparative Performance Of Rotorex And Angiojet For Clot Removal From Lower Extremity Arteries: Advantages And Limitations Of Each |
Presenter(s):Hermann Steinkamp, MD | |
4:16 PM - 4:21 PM | A New Device To Treat Resistant Hypertension By Carotid Baroreceptor Stimulation: The BAROSTIM Trial |
Presenter(s):Fred A. Weaver, MD | |
View Abstract | |
4:22 PM - 4:29 PM | Routine Use Of Ultrasound Guidance And Micropuncture Makes Endovascular Access Safer: How To Do It |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
4:30 PM - 4:37 PM | Panel Discussion |
END OF SESSION 48 | |
SESSION 49 SCHEDULE | |
Saturday
SESSION 49:
NEW TECHNIQUES; NEW CONCEPTS (5-MINUTE TALKS)
Moderators:Alan B. Lumsden, MD, FACS / John J. Ricotta, MD
|
|
x | |
4:38 PM - 4:43 PM | Laparoscopic Treatment Of The Arcuate Ligament Syndrome: Technique, Indications And Results |
Presenter(s):Yves Alimi, MD | |
4:44 PM - 4:49 PM | Is There Still A Place For Unilateral And Even Bilateral Hypogastric Embolization In 2012: How Safe Is It |
Presenter(s):Dieter Raithel, MD, PhD | |
View Abstract | |
4:50 PM - 4:55 PM | Hypogastric Preservation In Patients With Common Iliac Aneurysms Using Off-The-Shelf Devices |
Presenter(s):Karthikeshwar Kasirajan, MD | |
4:56 PM - 5:01 PM | Unusual Causes Of Upper Extremity Arterial Occlusive Disease |
Presenter(s):Kenneth J. Cherry, MD | |
5:02 PM - 5:07 PM | Catheter Directed Prostaglandins Are An Effective Treatment For CLI: As The Sole Treatment Or As An Adjunct To Other Endovascular Therapy |
Presenter(s):Oscar L. Ojeda, MD / Marcelo Patero, MD | |
View Abstract | |
5:08 PM - 5:13 PM | Carotid Interventions For Acute Stroke: When Are They Worthwhile And When Are They Not |
Presenter(s):R. Clement Darling III, MD | |
View Abstract | |
5:14 PM - 5:19 PM | How Do Pericardial Patches Heal And Why Are They Likely To Resist Infection |
Presenter(s):Alan Dardik, MD, PhD | |
5:20 PM - 5:25 PM | Imaging And Endovascular Techniques In The Removal Of Transvenous Pacer And ICD Leads |
Presenter(s):Ali Khoynezhad, MD, PhD | |
View Abstract | |
5:26 PM - 5:31 PM | Update On Treatment Of Infected Abdominal And Thoracic Endografts: Is It A Solvable Or Hopeless Problem And Is Non-Excisional Treatment Ever Successful |
Presenter(s):Peter R. Taylor, MA, MChir, FRCS, ARCM | |
View Abstract | |
5:32 PM - 5:37 PM | Non-Atherosclerotic Aortic Thrombosis: Causes, Diagnosis And Treatment |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
5:38 PM - 5:43 PM | The SoloPath Expandable Introducer Sheath: How Does It Work And How Can It Be Helpful In EVAR Procedures |
Presenter(s):Jeffrey P. Carpenter, MD | |
5:44 PM - 5:49 PM | Management Of Infected CEA Patches: A 10-Year Experience |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
5:50 PM - 5:55 PM | In Situ Fenestration For Left Subclavian Revascularization During TEVAR Is Safer And Better Than Carotid Subclavian Bypass: How To Do It |
Presenter(s):Frank R. Arko, MD | |
5:56 PM - 6:01 PM | Bell Bottom Iliac Limbs Have A Downside |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
6:02 PM - 6:10 PM | Panel Discussion |
END OF SESSION 49 | |
SESSION 50 SCHEDULE | |
Saturday
SESSION 50:
UPDATES, NEW TECHNOLOGY, NEW CONCEPTS (5-MINUTE TALKS)
Moderators:Herbert Dardik, MD / Dhiraj M. Shah, MD
|
|
x | |
3:10 PM - 3:15 PM | Current Optimal Treatment Of Atrial Fibrillation In Vascular Patients |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
3:16 PM - 3:21 PM | Prevalence Of Carotid Stenosis Varies According To Race: Highest In Caucasians And Native Americans |
Presenter(s):Caron B. Rockman, MD | |
3:22 PM - 3:27 PM | Ehrlos-Danlos Patients Can Have Endovascular Procedures Performed Safely: What Precautions Are Needed |
Presenter(s):James H. Black III, MD | |
3:28 PM - 3:33 PM | Bioabsorbable Scaffolds (REMEDY Stent), DEBs And DESs, In The SFA: What Is Their Future |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
3:34 PM - 3:39 PM | Can The Achilles Tendon Be Excised Safely And With Minimal Disability To Treat Bad Heel Wounds And Plantar Pedal Ulcers |
Presenter(s):Wayne Caputo, DPM / Clifford M. Sales, MD, MBA | |
3:40 PM - 3:45 PM | Drug Eluting Balloon Evaluation For Lower Limb Multilevel Treatment – DEBELLUM Trial: 1-Year Results |
Presenter(s):Fabrizio Fanelli, MD / Plinio Rossi, MD | |
3:46 PM - 3:51 PM | Bypasses For Hand Digital Ischemia: What Is Their Role And Their Results |
Presenter(s):R. Clement Darling III, MD | |
View Abstract | |
3:52 PM - 3:57 PM | Retrohepatic Balloon Occlusion Of The IVC For Trauma And Renal Cell Cancer: How To Do It With Current Technology |
Presenter(s):Joseph S. Giglia, MD | |
3:58 PM - 4:03 PM | Carotid-To-Axillary Bypass Is Useful As A Debranching Technique And Easier And Less Risky Than Carotid-To-Subclavian Bypass |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
4:04 PM - 4:09 PM | VIATORR Covered Stent For Early TIPS And Its Effect On Hepatic Encephalopathy And Ascites: Other New Horizons In TIPS |
Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
4:10 PM - 4:15 PM | Which Post EVAR Patients Need Minimal Follow-up Surveillance: What Should That Consist Of |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
4:16 PM - 4:21 PM | Angioslide Angioplasty Balloon With Embolic Capture (Proteus Device): When To Use It And Evidence Of Effectiveness |
Presenter(s):Peter C.J. Goverde, MD | |
4:22 PM - 4:27 PM | Outcomes Of Endovascular Treatment Of Lower Extremity Lesions Are Worse In Young Patients (<50) |
Presenter(s):Rabih A. Chaer, MD | |
4:28 PM - 4:34 PM | Panel Discussion |
END OF SESSION 50 | |
SESSION 51 SCHEDULE | |
Saturday
SESSION 51:
MORE NEW CONCEPTS, UPDATES AND NEW TECHNIQUES (5-MINUTE TALKS)
Moderators:Enrico Ascher, MD / Palma M. Shaw, MD
|
|
x | |
4:34 PM - 4:39 PM | Limitations Of A Large Palmaz Stent For Treating Type I Endoleaks |
Presenter(s):Tilo Koelbel, MD, PhD | |
4:40 PM - 4:45 PM | Recent Volumetric Analyses Of Post EVAR AAA Sac Behavior: Is Sac Enlargement Still A Concern |
Presenter(s):Mark F. Fillinger, MD | |
4:46 PM - 4:51 PM | 2-Stage Treatment For Aorto-Enteric Fistulas Following Aortic Reconstruction: A New Better Way |
Presenter(s):Gioacchino Coppi, MD | |
4:52 PM - 4:57 PM | Siena Score For Evaluating AAAs Suitability For EVAR: What Is It And How Does It Help |
Presenter(s):Francesco Setacci, MD | |
View Abstract | |
4:58 PM - 5:03 PM | Advantages And Early Results Of The ALTURA Ultra Low Profile AAA Endograft |
Presenter(s):Albrecht H. Kramer, MD | |
5:04 PM - 5:09 PM | Fascial Suture To Close Large Percutaneous Sheath Insertion Sites Cheaply And Effectively (The Larzon Technique): Tips And Tricks |
Presenter(s):Timothy A. Resch, MD, PhD | |
5:10 PM - 5:15 PM | Cost Per Day Of Patency In Endo vs. Open Lower Extremity Revascularization Procedures |
Presenter(s):Manish Mehta, MD, MPH | |
5:16 PM - 5:21 PM | Current Status Of Silver Impregnated Grafts To Treat Aortic Infection: Are We In The US Being Denied A Valuable Treatment Adjunct |
Presenter(s):Max Zegelman, MD, PhD | |
View Abstract | |
5:22 PM - 5:27 PM | Antibiotic Drug Delivery Implants Facilitates Treatment Of Some Infected Vascular Prosthetic Grafts |
Presenter(s):Dennis F. Bandyk, MD | |
5:28 PM - 5:33 PM | DW-MRI Based Evidence That Interruption Of Flow Embolic Protection With The MoMa Device Is Effective During CAS (The DESERVE Trial) |
Presenter(s):Giancarlo Biamino, MD, PhD | |
5:34 PM - 5:39 PM | Optimal Current Use Of Anticoagulants And Antiplatelet Drugs In Patients Undergoing CEA |
Presenter(s):Timothy M. Sullivan, MD | |
5:40 PM - 5:45 PM | Causes And Implications Of 30-Day Readmissions After AAA Repair: Endo And Open |
Presenter(s):K. Craig Kent, MD | |
5:46 PM - 5:51 PM | BASIL Survival Prediction Model In Patients With CLI: Validation And Comparison With PREVENT And FINNUVASC Scores |
Presenter(s):Robert J. Hinchliffe, MD | |
5:52 PM - 5:57 PM | Importance Of Pressure Gradients In Assessing Hemodynamic Significant Vascular Lesions: A Simple Method To Measure Them |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
5:58 PM - 6:05 PM | Panel Discussion |
END OF SESSION 51 |